Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Sullivan

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Oncotarget|October 21, 2014
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsHatem H Soliman, Erica Jackson, Tony Neuger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantationJanelle B Perkins, Jongphil Kim, Claudio Anasetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignanciesChristopher R Garrett, Mayer N Fishman, Randall R Rago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancerAlberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
Digestive Diseases and Sciences|January 29, 2008
Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapiesJosé Cangiano, Barbara A Centeno, Christopher R Garrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumorsAlberto A Chiappori, S Gail Eckhardt, Ronald Bukowski, et al.
The Oncologist|October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid LeukemiaKendra Sweet, Rami Komrokji, Eric Padron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignanciesMayer N Fishman, Christopher R Garrett, George R Simon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlatesJanelle B Perkins, Steven C Goldstein, Jana L Dawson, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Oncotarget|October 21, 2014
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumorsHatem H Soliman, Erica Jackson, Tony Neuger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantationJanelle B Perkins, Jongphil Kim, Claudio Anasetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignanciesChristopher R Garrett, Mayer N Fishman, Randall R Rago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancerAlberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
Digestive Diseases and Sciences|January 29, 2008
Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapiesJosé Cangiano, Barbara A Centeno, Christopher R Garrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumorsAlberto A Chiappori, S Gail Eckhardt, Ronald Bukowski, et al.
The Oncologist|October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid LeukemiaKendra Sweet, Rami Komrokji, Eric Padron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignanciesMayer N Fishman, Christopher R Garrett, George R Simon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlatesJanelle B Perkins, Steven C Goldstein, Jana L Dawson, et al.
Pageof 9